Pignier Christophe, Revenaz Coralie, Rauly-Lestienne Isabelle, Cussac Didier, Delhon André, Gardette Jean, Le Grand Bruno
Division des Maladies Cardiovasculaires II, Centre de Recherche Pierre Fabre, Castres cedex, France.
Basic Res Cardiol. 2007 Nov;102(6):553-64. doi: 10.1007/s00395-007-0676-x. Epub 2007 Sep 24.
Polyunsaturated fatty acids (PUFAs) such as docosahexaenoic and eicosapentaenoic acids (DHA, EPA) exert ischemic anti-arrhythmic effects. However, their mechanism of action remains unknown. The present study was designed to investigate their potential effect on the regulation of the late sodium current as the basis for their ischemic anti-arrhythmic activity. Human isoforms of wild-type SCN5A and DeltaKPQ-mutated cardiac sodium channels were stably transfected in HEK 293 cells and, the resulting currents were recorded using the patch clamp technique in whole cell configuration. In addition to their effect to inhibit peak I(Na), acute application of DHA and EPA blocked veratridine-induced late sodium current (late I(Na-Verat)) in a concentration--dependent manner with IC(50) values of 2.1 +/- 0.5 microM and 5.2 +/- 0.8 microM,for DHA and EPA, respectively. Channels availability was reduced, resulting in a significant leftward shift of the steadystate inactivation curve by -10.0 +/- 2.1 mV and -8.5 +/- 0.2 mV for DHA and EPA, respectively. Similar inhibitory effects of DHA and EPA were also observed on late I(Na-KPQ). In addition to their role as blocking agents of peak I(Na), DHA and EPA reduced human late I(Na). These results could explain the antiarrhythmic properties of DHA and EPA during ischemia or following ischemia-reperfusion.
多不饱和脂肪酸(PUFAs),如二十二碳六烯酸和二十碳五烯酸(DHA、EPA)具有缺血性抗心律失常作用。然而,它们的作用机制尚不清楚。本研究旨在探讨它们对晚期钠电流调节的潜在影响,作为其缺血性抗心律失常活性的基础。野生型SCN5A和DeltaKPQ突变的心脏钠通道的人类异构体在HEK 293细胞中稳定转染,并使用全细胞膜片钳技术记录产生的电流。除了抑制峰值I(Na)的作用外,急性应用DHA和EPA以浓度依赖性方式阻断了藜芦碱诱导的晚期钠电流(晚期I(Na-Verat)),DHA和EPA的IC(50)值分别为2.1±0.5 microM和5.2±0.8 microM。通道可用性降低,导致稳态失活曲线分别向左显著偏移-10.0±2.1 mV和-8.5±0.2 mV,DHA和EPA的情况分别如此。在晚期I(Na-KPQ)上也观察到了DHA和EPA的类似抑制作用。除了作为峰值I(Na)的阻断剂外,DHA和EPA还降低了人类晚期I(Na)。这些结果可以解释DHA和EPA在缺血期间或缺血再灌注后的抗心律失常特性。